Longfellow Real Estate Partners

Embedded within the diverse cultural fabric of Long Island City, Longfellow Real Estate Partners state-of-the-art lab spaces at Hatch Life Sciences provide a platform for companies to propel their innovations to the next level. As we welcome our new partners from JLL - Bill Harvey, John Cahill, and Thomas Burrus - our team is excited to double down on the development's unique offerings of fitted labs, highly curated amenity center, and creative deal strategies. To learn more about this exciting opportunity, visit: www.HatchLifeSciences.com

A well-deserved congratulations are in order for Inceptor Bio, a clinical-stage biotechnology company pioneering next-generation cell therapies, as their team announced that the first patient has been dosed in the clinical trial of IB-T101, the company’s lead program. In conjunction with this milestone, Inceptor Bio has successfully closed a $21 million Series A2 financing, which will support the ongoing clinical development of IB-T101 and the expansion of its next-generation cell therapy pipeline. The round was led by a syndicate of insiders including Kineticos Life Sciences. Longfellow Real Estate Partners is proud to partner with Inceptor Bio at our Discovery at Perimeter Park Campus in the heart of North Carolina's Research Triangle Park. For full release and details, visit: https://lnkd.in/eFxAE838

FEATURED: A big thank you goes to our United Kingdom media partners at Estates Gazette for their latest in-depth story outlining the Longfellow Real Estate Partners campus transformation at CamLIFE in Cambridge, UK! The first phase of the 42-acre campus developments will be delivered in July and December of this year, creating c.170,000 sq ft of adaptable lab space across three buildings. Meanwhile, progress continues to be made on the fully curated amenity building, which will feature Longfellow's Elevate brand within CamLIFE's historic Victoria House. For full story, visit: https://lnkd.in/eH8iVcyC

Last week, leaders from throughout the North Carolina community came together to celebrate the grand opening and ribbon cutting ceremony for Longfellow Real Estate Partners newest partner in the Durham Innovation District, Virge Yoga! The shared passion to transform our community, and the lives of our neighbors, was on full display through the work Virge Yoga's founder, Jodi Myers, along with attendees from remarkable groups such as the Greater Durham Chamber of Commerce, Downtown Durham, Inc., and so many more. For more information, visit: https://lnkd.in/gwB-4UX7

Last week, Longfellow Real Estate Partners and our UK Managing Director, Tom French had the pleasure of hosting Sir James Wates and Wates Group for a tour of the latest progress on the revolutionary CamLIFE campus in Cambridge, UK. The 42-acre life science innovation campus combines fitted+ lab space, integrated offices, and highly curated lifestyle amenities across multiple Class A properties. Don't miss the chance to jump in (virtually) to our fitted lab tour here: https://lnkd.in/eCaXsT5s

📰 Congratulations to Tune Therapeutics, a proud partner of Longfellow Real Estate Partners at our Durham ID development in North Carolina, as they announce the completion of over $175M in Series B financing to advance field-leading epigenome editing programs! The funding will accelerate the development of the company’s existing pipeline, currently anchored by Tune-401 – its clinical-stage epigenetic silencing drug for chronic Hepatitis B (HBV). It will also support the development of additional gene, cell, and regenerative therapy programs already underway at Tune, and to progress its broader mission of bringing the power and versatility of epigenetic therapies to bear on common and chronic diseases. For full details and release, visit: https://lnkd.in/exKh5c5t

Thanks to our incredible partners at HOK for naming Longfellow Real Estate Partners' upcoming development Bioterra in San Diego as one of their most anticipated deliveries of 2025! The upcoming life science development is set to make history as the first all-electric life science campus in San Diego, complimenting the location's modern labs and office suites as well as exceptional amenities, including a café, fitness center, conference center and rooftop patio. For more information, visit: https://lnkd.in/efvd7Fr8

From the Triangle Business Journal - Longfellow Real Estate Partners welcomes Virge Yoga as the newest partner in the Durham Innovation District! North Carolina favorite Virge Yoga opened its first brick-and-mortar studio in the heart of Durham ID to kick off the 2025 calendar year. Designed to revolutionize the yoga experience, Virge Yoga integrates the art of yoga with the pillars of Lifestyle Medicine to create a whole body Wellness Sanctuary that is both affordable and accessible to all. For full recap of the announcement, visit: https://lnkd.in/ePjqGtMj

FEATURED: Longfellow Real Estate Partners project Preserve Labs in Rockville, Maryland, was highlighted in the latest edition of Building Washington Magazine for the development's revolutionary conversion - one that saw the campus transformed from office space to a Class A, lab and innovation magnet in the Washington D.C. metro region. Highlighted alongside Longfellow were project partners HITT Contracting Inc., Capital Welding, Rock Spring Contracting, Limbach, and Kent Island Mechanical as the outlet caught up with Longfellow's Senior Project Manager Larry Chen and Director of Corporate Communications Casey Angel for insights to the development. Full article and details: https://lnkd.in/eBNygNQV

Congratulations are in order for ReCode Therapeutics, a proud partner of Longfellow Real Estate Partners, for their recent announcement of new funding from the Cystic Fibrosis Foundation (CF Foundation) to support ReCode’s gene correction research program with the goal of developing and commercializing new treatments for people with cystic fibrosis. “We are grateful to the CF Foundation for their ongoing support of our efforts to develop novel treatments for people living with cystic fibrosis,” said Shehnaaz Suliman, M.D., MBA, M.Phil., chief executive officer of ReCode Therapeutics. “This funding will support our gene correction approach, enabling us to significantly accelerate research in collaboration with Intellia and to advance the development of a potentially transformative treatment for CF. Along with RCT2100, our inhaled mRNA program, we are building a therapeutic franchise with the goal of expanding disease-modifying treatment options for all people with CF.” For full story and details, visit: https://lnkd.in/gy-qSjGR